المؤلفون: Takenaka K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan., Kawamoto A; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Hibiya S; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan., Suzuki K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan., Fujii T; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Motobayashi M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Shimizu H; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Nagahori M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Saito E; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Okamoto R; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan., Watanabe M; TMDU Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan., Ohtsuka K; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.

المصدر: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Oct; Vol. 54 (8), pp. 1052-1060. Date of Electronic Publication: 2021 Jul 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Crohn Disease*/drug therapy, Cytokines/*antagonists & inhibitors, Adalimumab/therapeutic use ; Cross-Sectional Studies ; Humans ; Infliximab/therapeutic use ; Remission Induction ; Treatment Outcome

المؤلفون: Takenaka, Kento, Kawamoto, Ami, Ohtsuka, Kazuo

المصدر: Alimentary Pharmacology & Therapeutics; Oct2021, Vol. 54 Issue 8, p1087-1087, 1p

مصطلحات موضوعية: CROHN'S disease, SMALL intestine, CYTOKINES, HEALING